Close Menu

Illumina NovaSeq 6000 v1.5 Reagent Kit

Illumina has launched a new NovaSeq 6000 reagent kit that the company said could reduce sequencing costs for a human genome to $600.

The v1.5 kit offers improved quality, with an average Q30 score above 85 percent for read lengths up to 2x150 bp. Additional cycles per kit enables full support for unique molecular identifiers. The kits also double shelf life — up to six months — and are compatible with the new Illumina DNA PCR-Free Prep kit.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports the US National Institutes of Health is investing in studies of the long-term effects of COVID-19.

The National Health Service is to offer Novartis's Zolgensma for spinal muscular atrophy later this year, according to the Guardian.

Taiwan is to launch a pilot program offering genetic testing to cancer patients, the Taipei Times reports.

In PLOS this week: loci linked to protection against tuberculosis, identification of loci associated with increased risk of squamous cell carcinoma of the aerodigestive tract, and more.